Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

11C-Methionine PET of Acute Myocardial Infarction

Miyako Morooka, Kazuo Kubota, Hiromu Kadowaki, Kimiteru Ito, Osamu Okazaki, Mitsuo Kashida, Takuya Mitsumoto, Ren Iwata, Kuni Ohtomo and Michiaki Hiroe
Journal of Nuclear Medicine August 2009, 50 (8) 1283-1287; DOI: https://doi.org/10.2967/jnumed.108.061341
Miyako Morooka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuo Kubota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiromu Kadowaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimiteru Ito
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osamu Okazaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsuo Kashida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takuya Mitsumoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ren Iwata
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuni Ohtomo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiaki Hiroe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Tissue uptake of l-[methyl-11C]-methionine (11C-methionine) has been used to monitor amino acid metabolism and protein synthesis. We examined whether 11C-methionine was retained in areas of myocardial infarction after successful reperfusion. Methods: Nine patients with infarction in the left anterior descendent region underwent percutaneous transluminal coronary artery intervention within 24 h and 201Tl SPECT, 18F-FDG PET, and 11C-methionine PET within 2 wk of infarction onset. The standardized uptake values of the infarcted area and of the normal area were measured. Results: The 11C-methionine images showed increased uptake in the infarcted area, whereas the 201Tl SPECT and 18F-FDG PET images showed decreased uptake. The highest accumulation of 11C-methionine in the infarcted area was observed during the early phase of AMI. Conclusion: 11C-methionine uptake is elevated in infarcted areas and may reflect the early acute phase of damage healing, that is, the initial process of remodeling.

  • 11C-methionine
  • myocardial infarction
  • PET
  • 18F-FDG
  • remodeling

Labeled amino acids such as l-[methyl-11C] methionine (11C-methionine) have been used mainly for the diagnosis of brain and other tumors (1–4). 11C-methionine uptake reflects not only protein synthesis but also amino acid transport and transmethylation (2). Several reports on cerebral infarction and gliomas have suggested a relation between 11C-methionine uptake and angiogenesis (4–6). However, few studies have examined 11C-methionine uptake in the myocardium since Barrio et al. first reported the use of various amino acids labeled with 13N and 11C-labeled l-amino acids about 25 y ago (7); in their report, they demonstrated a higher retention in ischemic segments than in control segments in a dog model of ischemia and reperfusion.

The purpose of this study was to investigate whether 11C-methionine accumulates in infarcted areas after successful reperfusion. We hypothesized that 11C-methionine uptake might occur in infarcted areas after reperfusion and might reflect the early acute phase of damage healing, that is, the initial process of remodeling.

MATERIALS AND METHODS

Subjects and Study Protocol

The study protocol was approved by the Institutional Review Board, and written informed consent was obtained from each patient on entry into the study. The subjects consisted of 9 patients with acute myocardial infarction (AMI) in the anterior or anteroseptal wall who had undergone a percutaneous transluminal coronary artery intervention resulting in successful revascularization within 24 h after AMI onset. All patients underwent 201Tl SPECT (mean day, 3.9), 18F-FDG (7.2), and 11C-methionine PET (6.6) within 2 wk of AMI onset. In addition, to enable a preliminary evaluation of the time course, we also evaluated 2 patients who had undergone follow-up studies at 3 or 6 mo after AMI onset.

201Tl SPECT

We performed 201Tl SPECT within 1 wk after a successful percutaneous transluminal coronary artery intervention. The patients were intravenously injected with 111 MBq of 201Tl. One hour after the injection, myocardial SPECT images were obtained using a digital γ-camera and low-energy high-resolution collimators (ECAM; Siemens) according to the standard protocol.

18F-FDG PET

After 6 h of fasting, the patients were orally given 75 g of glucose and their blood glucose level was measured 1 h later; 18F-FDG (370 MBq) was then injected intravenously. If an elevated blood glucose level was observed, regular insulin was injected according to the guidelines of the American Society of Nuclear Cardiology (8). One hour after 18F-FDG injection, PET/CT (Biograph 16; Siemens) of the heart was performed with a 7-min emission scan per bed position (1 bed position covered a 16-cm field of view along the z-axis) and CT attenuation correction. PET data were reconstructed with an ordered-subset expectation maximization algorithm (3 iterations, 8 subsets) using a Hanning filter.

11C-Methionine PET

11C-methionine was synthesized by the reaction of 11C-methyltriflate with an aqueous solution of l-homocysteine thiolactone on a Sep-Pak tC18 cartridge (Waters) followed by purification with ion exchange cartridges (9). The radiochemical purity of the 11C-methionine was more than 99%, and its clinical use was approved by the Institutional Review Board.

After 6 h of fasting, the patients were intravenously injected with 370 MBq of 11C-methionine. Twenty minutes after injection, PET/CT of the heart was performed with an 8-min emission scan per bed position and CT attenuation correction. The reconstruction of the PET data was the same as that used for 18F-FDG PET.

Before the patients had been examined, 3 healthy volunteers (2 men and 1 woman) were examined to determine the optimal timing of myocardial imaging after 11C-methionine injection; dynamic data was acquired for up to 60 min after 11C-methionine injection, and PET images of 11C-methionine uptake in normal myocardium were thus obtained (Fig. 1A). In the normal myocardium, 11C-methionine uptake was almost homogeneous, with a tendency toward a slight elevation in the basal anteroseptal area. In 2 volunteers, the average standardized uptake values (SUVs) of the basal anterior wall were 2.0 and 1.96 and those of the lateral wall were 1.71 and 1.78; the ratios of uptake in the basal anterior wall to the lateral wall were 1.17 and 1.10. Physiologic uptake in the liver was high, and this uptake masked some segments of the inferior wall. Patients with inferior-wall myocardial infarctions were also examined but were not included in the present study; instead, only cases of left anterior descendent infarction were chosen.

FIGURE 1. 
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1. 

(A) Time–activity curves of regions of interest after tracer administration: whole left ventricle (red) and left ventricular blood pool (green). Blood-pool activity decreased from initially steep curve to stable lower level at around 20 min after injection, resulting in higher and stable myocardium–to–left-ventricle contrast at 20 min and thereafter. Then, we determined imaging time of myocardium with 11C-methionine at 20 min after injection. (B) Comparison of infarction-to-normal SUV ratios (SUV i/n) on 18F-FDG and 11C-methionine images (P < 0.005 vs. 11C-methionine imaging: mean ± SD, unpaired t test). (C and D) 201Tl SPECT, 18F-FDG PET, and 11C-methionine PET in 53-y-old man (patient 7) (C) and 71-y-old man (patient 9) (D). In 11C-methionine images, physiologic uptake in liver was high. Infarction zone in anterior wall exhibited decreased uptake on 201Tl and 18F-FDG images and increased uptake on 11C-methionine images. 11C-methionine uptake increased more in middle anterior wall than in apex: highest zone of uptake was almost next to spare zone in 201Tl and 18F-FDG images. 201Tl images were similar to 18F-FDG images visually. However, direct comparisons are difficult because of the different modalities. (E) Another instance of 3 orthogonal views of patient with segment 9 AMI (patient 8). Relative increase in11C-methionine uptake is also apparent in this patient.

Analysis of SPECT and PET Images

First, we visually assessed uptake of the 3 tracers semiquantitatively by categorizing the regional uptake as greater than, less than, or similar to uptake in normal cardiac tissue. Next, to analyze 18F-FDG and 11C-methionine uptake in the PET images quantitatively, we determined the average SUVs of infarcted areas (infarction SUVs) and normal areas (normal SUVs) by placing regions of interest at corresponding places on short axial and long vertical views. The lateral wall was defined as a normal area, since stenosis of the coronary artery was not apparent on coronary angiography in any patient. The mean infarction and normal SUVs were calculated from 3 regions of interest in each area. The infarction-to-normal SUV ratio was also calculated. For 201Tl, the average counts per pixel were determined in the infarction and normal zones, and the infarction-to-normal count ratio was calculated. All data were presented as the mean ± SD, and statistical differences were examined using an unpaired t test.

RESULTS

201Tl and 18F-FDG uptake was decreased, whereas 11C-methionine uptake was similar or increased, relative to the normal region on semiquantitative visual analysis (Table 1). Table 1 summarizes the clinical information and analyzed data of the 9 patients (mean age, 57.1 ± 15.1 y; female-to-male ratio, 0:9). All infarction-to-normal count ratios were lower than 1.0 in the 201Tl images. All infarction SUVs were lower than normal SUVs in the 18F-FDG images, whereas all infarction SUVs were similar to or higher than normal SUVs in the 11C-methionine images. Using the SUVs for all 9 patients, we determined the infarction-to-normal SUV ratio (mean ± SD) to be 0.39 ± 0.128 for the 18F-FDG images and 1.207 ± 0.095 for the 11C-methionine images (Fig. 1B). Representative patients are shown in Figures 1C–1E. Two patients with segment 6 AMI (Figs. 1C and 1D) exhibited increased uptake of 11C-methionine in the infarct zone, although uptake of the other tracers was decreased in the same zone. The greatest 11C-methionine uptake was not in the core of the infarct region but in the border region between the infarct and normal tissue. Visually, relative 18F-FDG uptake was reduced in the infarction zone, and the 201Tl uptake was the same. Three orthogonal views of another patient with no. 9 AMI are shown in Figure 1E. A relative increase in 11C-methionine uptake is visible. Figure 2 shows the changes in 11C-methionine uptake in studies performed 1 wk and 3 mo (patient 3) and 6 mo (patient 7) after AMI onset. At 3 mo after onset, uptake of 11C-methionine was similar to that observed during the acute phase, whereas uptake was decreased or showed a partial defect at 6 mo after onset. The 11C-methionine infarction-to-normal SUV ratio also decreased in 2 patients (Table 1). Thus, 11C-methionine uptake changed during imaging studies performed over the course of 6 mo after AMI onset.

FIGURE 2. 
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2. 

Vertical long-axis images obtained 1 wk and 3 mo after AMI onset in 60-y-old man (patient 3) (A) and 1 wk and 6 mo after AMI onset in 53-y-old man (patient 7) (B). In both patients, 11C-methionine uptake in region was higher than that in lateral wall at 1 wk after AMI onset (infarction-to-normal ratios, 1.12 and 1.10). However, uptake became similar to 18F-FDG uptake at 3 mo after AMI onset and almost undetectable after 6 mo (infarction-to-normal ratios, 0.80 and 0.77). Uptake was slightly increased around infarction zone in 18F-FDG images obtained at 3 mo after AMI onset, whereas decreased 18F-FDG uptake was observed at 6 mo.

View this table:
  • View inline
  • View popup
TABLE 1

Clinical Information and Quantitative Data of Patients

DISCUSSION

11C-methionine PET has been used for diagnosing brain tumors and evaluating their treatment (1–4). Because of the low physiologic uptake of 11C-methionine in the brain, 11C-methionine PET is currently used mainly to assess brain tumors. Numerous studies have examined 11C-methionine uptake, and 11C-methionine uptake is widely known to reflect amino acid transport, transmethylation, and protein synthesis. In particular, Ishiwata et al. reported that the amino acid transport system was dominant in the brain and in tumors (2). Kracht et al. demonstrated a correlation between 11C-methionine uptake and microvessel density and showed a strong correlation between increased amino acid uptake and angiogenesis in evolving gliomas (4). In studies on brain infarction, Jacobs observed an increase in 11C-methionine uptake in peripheral areas of acute cerebral infarction (5), and Nagano-Saito et al. concluded that 11C-methionine uptake by damaged but viable brain tissue represented gliosis and angiogenesis (6).

However, few studies have examined the application of 11C-methionine PET to myocardial imaging, especially using clinical PET images. Here, we presented 201Tl SPECT and 18F-FDG/11C-methionine PET images of AMI after successful reperfusion. All the 201Tl and 18F-FDG images were typical of myocardial ischemia and exhibited similar uptake profiles. However, the 11C-methionine images showed a different pattern of uptake. An increase in 11C-methionine uptake was observed in regions exhibiting reduced or the absence of 201Tl and 18F-FDG uptake.

As we had suspected on the basis of the pattern of 11C-methionine uptake in the brain, 11C-methionine uptake was observed in regions of myocardial infarction. Blankesteijn et al. separated the process of healing after myocardial infarction into 4 phases: myocardial cell death, acute inflammation, the formation of granulation tissue, and scar formation (10). 11C-methionine uptake was observed in the second and third of these phases.

During the acute inflammatory reactions that occur during the early phase of healing, many inflammatory cells in the damaged region produce cytokines, which degrade the extracellular collagen matrix (11). In tumor tissue, 11C-methionine uptake increases in granulation tissue and macrophages, but not as much as does 18F-FDG (1). Thus, 11C-methionine uptake may reflect the activity of these inflammatory cells.

On the other hand, numerous small blood vessels are present during the formation of granulation tissue. Angiogenesis, a repair process after ischemic injuries (12), recently has become a field of molecular imaging research (13–17). 111In-RP748 SPECT (13) and 18F-galacto-RGD PET (14) targeting αvβ3 integrin, an angiogenic factor, have been used to study animal models of myocardial infarction; these studies showed overexpression of αvβ3 integrin in activated endothelial cells during angiogenesis after hypoxia, and increased uptake was observed in infarcted areas. The time course of the 11C-methionine images obtained after AMI was similar to the acute phase of angiogenesis described in these reports. Thus, the increased uptake of 11C-methionine might reflect some angiogenic factors, as mentioned in the above studies on cerebral infarction and gliomas, suggesting a relation between 11C-methionine uptake and angiogenesis. Possibly, the amino acid transport system might become active during remodeling of the heart, just as it does in the brain and in tumors.

This study had some limitations. 11C-methionine uptake was elevated during early AMI. This elevated uptake may gradually decrease until it disappears in scar tissue. 11C-methionine uptake after infarction may be useful for assessing the process of remodeling after AMI and for monitoring the effects of therapy. Further studies on 11C-methionine uptake after myocardial infarction are needed.

The present findings were limited to only the early acute phase of myocardial infarction, and more data on long-term changes in 11C-methionine uptake should be obtained.

In addition, although we compared 201Tl uptake for perfusion images, 18F-FDG for glucose metabolism, and 11C-methionine for amino acid metabolism, differences between the SPECT and PET modalities prevented us from determining whether the region of 11C-methionine uptake better matched the region of low 18F-FDG uptake or the region of 201Tl hypoperfusion.

Furthermore, because our 18F-FDG PET images were obtained after the oral administration of glucose, a comparison of 18F-FDG after fasting with heparin injection and 11C-methionine uptake would be useful to confirm whether 11C-methionine uptake actually reflects acute inflammation or ischemia.

Finally, from a technical viewpoint, the considerable physiologic uptake of 11C-methionine in the liver makes a detailed assessment of the right coronary artery area difficult.

CONCLUSION

We have presented the first (to our knowledge) images of 11C-methionine uptake in damaged myocardium after reperfusion for AMI. These images differ greatly from those of 201Tl and 18F-FDG uptake. 11C-methionine uptake might reflect an aspect of dynamic myocardial changes, such as remodeling during healing, after reperfusion for AMI.

Acknowledgments

We thank Drs. Yuriko Tanaka, Hiroyuki Soejima, Yuiichi Tamori, Munehiro Kamimura, Tomohiro Yamazaki, Junko Shibata, Kazuhiko Nakajima, and Ai Hori. Part of this study was supported by Grant-in-Aid 17-12 for cancer research from the Ministry of Health, Labor, and Welfare.

Footnotes

  • COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.

References

  1. 1.↵
    Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med. 1995;36:484–492.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Ishiwata K, Kubota K, Murakami M, et al. Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med. 1993;34:1936–1943.
    OpenUrlAbstract/FREE Full Text
  3. 3.
    Kubota K. From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med. 2001;15:471–486.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Kracht LW, Friese M, Herholz K, et al. Methyl-[11C]-L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging. 2003;30:868–873.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Jacobs A. Amino acid uptake in ischemically compromised brain tissue. Stroke. 1995;26:1859–1866.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Nagano-Saito A, Kato T, Wakabayashi T, et al. High- and moderately high-methionine uptake demonstrated by PET in a patient with a subacute cerebral infarction. Ann Nucl Med. 2001;15:387–391.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Barrio JR, Baumgartner FJ, Henze E, et al. Synthesis and myocardial kinetics of N-13 and C-11 labeled branched chain L-amino acids. J Nucl Med. 1983;24:937–944.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Bacharach SL, Bax JJ, Case J, et al. PET myocardial glucose metabolism and perfusion imaging: part I—guidelines for patient preparation and data acquisition. J Nucl Cardiol. 2003;10:543–554.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Watanabe T, Iwata R, Ishikawa Y, Sato T, Ishiwata K. Development of a miniature module for on-column preparation of [C-11]methionine from [C-11]methyl triflate. In: Abstracts of the 9th Congress of the World Federation of Nuclear Medicine and Biology; Oct. 22–27, 2006; Seoul, Korea. No. 3003, S93.
  10. 10.↵
    Blankesteijn WM, Creemers E, Lutgens E, Cleutjens JP, Daemen MJ, Smits JF. Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice. Acta Physiol Scand. 2001;173:75–82.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation. 2003;108:1395–1403.
    OpenUrlFREE Full Text
  12. 12.↵
    Khurana R, Simons M, Martin JF, Zachary IC. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation. 2005;112:1813–1824.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Meoli DF, Sadeghi MM, Krassilnikova S, et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest. 2004;113:1684–1691.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Higuchi T, Bengel FM, Seidl S, et al. Assessment of αvβ3 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res. 2008;78:395–403.
    OpenUrlAbstract/FREE Full Text
  15. 15.
    Haubner R, Weber WA, Beer AJ, et al. Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]galacto-RGD. PLoS Med. 2005;2:e70.
    OpenUrlCrossRefPubMed
  16. 16.
    Beer AJ, Haubner R, Goebel M, et al. Biodistribution and pharmacokinetics of the αvβ3-selective tracer 18F-galacto-RGD in cancer patients. J Nucl Med. 2005;46:1333–1341.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Hua J, Dobrucki LW, Sadeghi MM, et al. Noninvasive imaging of angiogenesis with a 99mTc-labelled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia. Circulation. 2005;111:3255–3260.
    OpenUrlAbstract/FREE Full Text
  • Received for publication December 17, 2008.
  • Accepted for publication May 7, 2009.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 50 (8)
Journal of Nuclear Medicine
Vol. 50, Issue 8
August 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
11C-Methionine PET of Acute Myocardial Infarction
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
11C-Methionine PET of Acute Myocardial Infarction
Miyako Morooka, Kazuo Kubota, Hiromu Kadowaki, Kimiteru Ito, Osamu Okazaki, Mitsuo Kashida, Takuya Mitsumoto, Ren Iwata, Kuni Ohtomo, Michiaki Hiroe
Journal of Nuclear Medicine Aug 2009, 50 (8) 1283-1287; DOI: 10.2967/jnumed.108.061341

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
11C-Methionine PET of Acute Myocardial Infarction
Miyako Morooka, Kazuo Kubota, Hiromu Kadowaki, Kimiteru Ito, Osamu Okazaki, Mitsuo Kashida, Takuya Mitsumoto, Ren Iwata, Kuni Ohtomo, Michiaki Hiroe
Journal of Nuclear Medicine Aug 2009, 50 (8) 1283-1287; DOI: 10.2967/jnumed.108.061341
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Imaging Inflammation Past, Present, and Future: Focus on Cardioimmunology
  • Molecular Imaging of Myocardial Inflammation With Positron Emission Tomography Post-Ischemia: A Determinant of Subsequent Remodeling or Recovery
  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET in Human Gliomas: Comparative Study with [18F]Fluorodeoxyglucose and L-Methyl-[11C]Methionine PET
  • 14C-Methionine Uptake as a Potential Marker of Inflammatory Processes After Myocardial Ischemia and Reperfusion
  • Targeted Metabolic Imaging to Improve the Management of Heart Disease
  • Methylphenidate-Elicited Dopamine Increases in Ventral Striatum Are Associated with Long-Term Symptom Improvement in Adults with Attention Deficit Hyperactivity Disorder
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire